[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336030-105":59,"doc-detail-336030-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"zh","research-progress-on-immunological-mechanisms-underlying-hepatocellular-carcinoma-caused-by-viral-hepatitis-infection","肝炎病毒感染导致肝细胞癌发生的免疫机制研究进展","","肝炎病毒感染是肝细胞癌的重要致病因素之一。甲型肝炎病毒多引起急性感染，但临床病理随访提示与肝细胞癌发生存在一定关联。乙型或丙型肝炎病毒的慢性感染可持续诱发肝脏炎症与肝硬化，扰动细胞凋亡与增殖相关多条信号通路，是最常见的病毒性前驱。HBV X蛋白突变与发病率密切相关，HCV核心蛋白表达可促进肝细胞脂质积累。丁型与戊型肝炎分别可增加慢性肝炎风险并推动向肝硬化及肝细胞癌进展。本文综述相关免疫应答异常与发病机制研究进展，为早期检测、干预与疫苗策略提供依据。",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/research-progress-on-immunological-mechanisms-underlying-hepatocellular-carcinoma-caused-by-viral-hepatitis-infection/336030/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/research-progress-on-immunological-mechanisms-underlying-hepatocellular-carcinoma-caused-by-viral-hepatitis-infection/336030.png","ImageObject",300,407,{"name":92,"@type":93},"Finn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"肝炎病毒感染如何促使肝细胞癌发生？","Question",{"text":113,"@type":114},"肝炎病毒感染可引发持续性肝脏炎症与肝硬化，并扰动与细胞凋亡和增殖相关的多条信号通路，从而推动肿瘤发生。","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"HBV和HCV在肝细胞癌风险中分别有哪些关键机制？",{"text":118,"@type":114},"HBV X蛋白（HBx）基因突变与肝细胞癌发病率密切相关；HCV核心蛋白表达可促进肝细胞脂质积累，进而促进肿瘤发生。",{"name":120,"@type":111,"acceptedAnswer":121},"为什么需要关注HDV与HEV相关的慢性感染进展？",{"text":122,"@type":114},"HDV常与HBV共感染，增加慢性肝炎风险；HEV虽多为急性感染，但近年来在免疫缺陷与器官移植患者中慢性感染增多，易导致肝硬化并增加肝细胞癌风险。","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},336030,1790468625,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":140,"language_code":63,"site_id":62,"html_lang":141,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":4},34359740700684,"https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487","Open Access  \n肿瘤免疫  \nDOI：10 .3724/zdxbyxb-2023-0481 ·专题报道 ·  \n肝炎病毒感染导致肝细胞癌发生的免疫机制研究进展  \n徐令东1，2，徐逸帆3，张 飞3，4，徐平龙3，4，5，6，汪 洌1，2  \n1.浙江大学实验动物中心，浙江杭州310058  \n2.浙江大学医学院，浙江杭州310058  \n3.浙江大学生命科学研究院，浙江杭州310058  \n4.浙江大学杭州国际科创中心智能医药研究所，浙江杭州311200  \n5.浙江大学生命系统稳态与保护教育部重点实验室 浙江省癌症分子细胞生物学重点实验室，浙江杭州310058  \n6.浙江大学癌症研究院，浙江杭州310058  \n［摘 要］ 肝炎病毒感染是肝细胞癌的主要致病因素之一。 甲型肝炎病毒（HAV）通常引起急性感染，临床病理长期追踪结果显示HAV感染与肝细胞癌发生有一定联系。 乙型肝炎病毒（HBV）或丙型肝炎病毒（HCV）的慢性感染可导致长期肝脏炎症和肝硬化，影响多条细胞凋亡和增殖相关信号通路，是病毒感染导致肝细胞癌的最常见诱因。 HBV X蛋白（HBx）基因突变与肝细胞癌发病率密切相关，HCV核心蛋白的表达可导致肝细胞脂质积累，促进肿瘤发生。 临床丁型肝炎病毒（HDV）感染常伴随HBV的共感染，从而增加慢性肝炎风险。 戊型肝炎病毒（HEV）感染通常呈急性，近年HEV在器官移植和免疫缺陷患者中慢性感染增多。 HEV慢性感染易导致肝硬化而增加肝细胞癌风险。 本文概述了近年来肝炎病毒感染导致肝脏免疫应答异常和肝细胞癌发生的研究进展，以期有助于寻找病毒感染的早期检测、有效干预和疫苗接种的措施。  \n［关键词］ 肝细胞癌；肝炎病毒；病毒性肝炎；肝硬化；慢性感染；综述［中图分类号］ R392 ［文献标志码］ A  \nImmunological pathways in viral hepatitis-induced hepatocellular carcinoma  \n收稿日期（Received）:2023-10-08 接受日期（Accepted）: 2023-12-25 网络预发表日期（Online）: 2024-01-19  \n基金项目（Funding）:浙江省自然科学基金（LQ22H 190003，LQ22C070001）；国家自然科学基金（31830052）；国家重点研发计划（2021YFA1301401）  \n第一作者（First author）:徐令东，助理研究员，主要从事戊型肝炎病毒致病机制和小动物感染模型研究；E-mail： [xulingdong@zju.edu.cn](xulingdong@zju.edu.cn)；[https](https：//orcid.org/0000-0002-5726-5419)[：](https：//orcid.org/0000-0002-5726-5419)[//orcid.org/0000](https：//orcid.org/0000-0002-5726-5419)[-](https：//orcid.org/0000-0002-5726-5419)[0002](https：//orcid.org/0000-0002-5726-5419)[-](https：//orcid.org/0000-0002-5726-5419)[5726](https：//orcid.org/0000-0002-5726-5419)[-](https：//orcid.org/0000-0002-5726-5419)[5419](https：//orcid.org/0000-0002-5726-5419)  \n通信作者（Corresponding author）:徐平龙，教授，博士生导师，主要从事分子细胞生物学和肿瘤学基础研究；E-mail： [xupl@zju.edu.cn](xupl@zju.edu.cn)；[https](https：//orcid.org/0000-0001-7726-5443)[：](https：//orcid.org/0000-0001-7726-5443)[//orcid.org/0000](https：//orcid.org/0000-0001-7726-5443)[-](https：//orcid.org/0000-0001-7726-5443)[0001](https：//orcid.org/0000-0001-7726-5443)[-](https：//orcid.org/0000-0001-7726-5443)[7726](https：//orcid.org/0000-0001-7726-5443)[-](https：//orcid.org/0000-0001-7726-5443)[5443](https：//orcid.org/0000-0001-7726-5443) .汪 洌，教授，博士生导师，主要从事免疫细胞分化发育功能研究；[E](E-mail：wanglie@zju.edu.cn)[-](E-mail：wanglie@zju.edu.cn)[mail](E-mail：wanglie@zju.edu.cn)[：](E-mail：wanglie@zju.edu.cn)[wanglie@zju.edu.cn](E-mail：wanglie@zju.edu.cn)；[https](https：//orcid.org/0000-0001-5094-012X)[：](https：//orcid.org/0000-0001-5094-012X)[//orcid.org/0000](https：//orcid.org/0000-0001-5094-012X)[-](https：//orcid.org/0000-0001-5094-012X)[0001](https：//orcid.org/0000-0001-5094-012X)[-](https：//orcid.org/0000-0001-5094-012X)[5094](https：//orcid.org/0000-0001-5094-012X)[-](https：//orcid.org/0000-0001-5094-012X)[012X](https：//orcid.org/0000-0001-5094-012X)  \nXU Lingdong1,2, XU Yifan3, ZHANG Fei3,4, XU Pinglong3,4,5,6, WANG Lie1,2（1. Laboratory Animal Center, Zhejiang University, Hangzhou 310058, China; 2. Zhejiang University School of Medicine, Hangzhou 310058, China; 3. Life Sciences Institute, Zhejiang University, Hangzhou 310058, China; 4. Institute of Intelligent Medicine, Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University, Hangzhou 311200, China; 5. Key Laboratory of Biosystems Homeostasis and Protection, Ministry of Education, Zhejiang Provincial Key Laboratory for Cancer Molecular Cell Biology, Zhejiang University, Hangzhou 310058, China; 6. Cancer Center, Zhejiang University, Hangzhou 310058, China）  \nCorresponding authors: XU Pinglong, E-mail: [xupl@zju. edu. cn](xupl@zju. edu. cn), [https://orcid. org/0000](https://orcid. org/0000-)[-](https://orcid. org/0000-)[ ](https://orcid. org/0000-)0001-7726-5443; WANG Lie, [E](E-mail: wanglie@zju.edu.cn)[-](E-mail: wanglie@zju.edu.cn)[mail: wanglie@zju.edu.cn](E-mail: wanglie@zju.edu.cn), [https://orcid.org/0000](https://orcid.org/0000-0001-)[-](https://orcid.org/0000-0001-)[0001](https://orcid.org/0000-0001-)[-](https://orcid.org/0000-0001-)[ ](https://orcid.org/0000-0001-)[5094](5094-012X)[-](5094-012X)[012X](5094-012X)  \n［Abstract］ Hepatocellular carcinoma (HCC) is a serious neoplas","cbCaikfGm40Or8g6","https://ap.wps.com/l/cbCaikfGm40Or8g6","pdf",1196937,"Chinese","en","# 肝炎病毒感染与肝细胞癌相关性\n## HAV与HBV/HCV等病毒的感染类型及影响\n## 关键病毒分子因素与致癌作用\n## HDV/HEV对慢性进展与肿瘤风险的贡献\n## 研究进展综述与干预策略启示","[{\"question\":\"肝炎病毒感染如何促使肝细胞癌发生？\",\"answer\":\"肝炎病毒感染可引发持续性肝脏炎症与肝硬化，并扰动与细胞凋亡和增殖相关的多条信号通路，从而推动肿瘤发生。\"},{\"question\":\"HBV和HCV在肝细胞癌风险中分别有哪些关键机制？\",\"answer\":\"HBV X蛋白（HBx）基因突变与肝细胞癌发病率密切相关；HCV核心蛋白表达可促进肝细胞脂质积累，进而促进肿瘤发生。\"},{\"question\":\"为什么需要关注HDV与HEV相关的慢性感染进展？\",\"answer\":\"HDV常与HBV共感染，增加慢性肝炎风险；HEV虽多为急性感染，但近年来在免疫缺陷与器官移植患者中慢性感染增多，易导致肝硬化并增加肝细胞癌风险。\"}]","肝炎病毒感染导致肝细胞癌发生的免疫机制研究进展 | PDF",1790013273,23]